Patents by Inventor Markus KRÜER

Markus KRÜER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260102476
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Application
    Filed: October 24, 2025
    Publication date: April 16, 2026
    Inventors: Janos CSIKOS, Irena PULTE, Michael ALTHAUS, Markus KRÜER, Nico WEGENER
  • Patent number: 12478663
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Grant
    Filed: November 10, 2022
    Date of Patent: November 25, 2025
    Assignee: Merz Pharma GmbH & Co. KGaA
    Inventors: Janos Csikos, Irena Pulte, Michael Althaus, Markus Krüer, Nico Wegener
  • Patent number: 10709772
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: July 14, 2020
    Assignee: Merz Pharma GmbH & Co. KGaA
    Inventors: Janos Csikos, Irena Pulte, Michael Althaus, Markus Krüer, Nico Wegener
  • Publication number: 20190000938
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Application
    Filed: September 12, 2018
    Publication date: January 3, 2019
    Inventors: Janos CSIKOS, Irena PULTE, Michael ALTHAUS, Markus KRÜER, Nico WEGENER